Global Alprostadil Injection Market Insights, Forecast to 2034
A prostaglandin
Global Alprostadil Injection market is expected to reach to US$ 1390.5 million in 2024, with a positive growth of %, compared with US$ 1350 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Alprostadil Injection industry is evaluated to reach US$ 1660.3 million in 2029. The CAGR will be 3.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Alprostadil Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Alprostadil Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Louston
CP Group
Yinglian Biopharmaceutical
Green Biology
HPGC
Swiss Parenterals
Endo Pharm
Ferring Pharmaceuticals
Hikma Pharmaceuticals
Lifespan Biotech
Viatris
Orifarm Group
Pfizer
Sandoz
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Segment by Type
0.5Mg/Ml
1Mg/Ml
2Mg/Ml
Other
Segment by Application
Myocardial Infarction
Thrombotic Vasculitis
Occlusive Arteriosclerosis
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Alprostadil Injection plant distribution, commercial date of Alprostadil Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Alprostadil Injection introduction, etc. Alprostadil Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Alprostadil Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Alprostadil Injection Product Introduction
1.2 Market by Type
1.2.1 Global Alprostadil Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 0.5Mg/Ml
1.2.3 1Mg/Ml
1.2.4 2Mg/Ml
1.2.5 Other
1.3 Market by Application
1.3.1 Global Alprostadil Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Myocardial Infarction
1.3.3 Thrombotic Vasculitis
1.3.4 Occlusive Arteriosclerosis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Alprostadil Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Alprostadil Injection Revenue by Region
2.2.1 Global Alprostadil Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Alprostadil Injection Revenue by Region (2018-2024)
2.2.3 Global Alprostadil Injection Revenue by Region (2024-2029)
2.2.4 Global Alprostadil Injection Revenue Market Share by Region (2018-2029)
2.3 Global Alprostadil Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Alprostadil Injection Sales by Region
2.4.1 Global Alprostadil Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Alprostadil Injection Sales by Region (2018-2024)
2.4.3 Global Alprostadil Injection Sales by Region (2024-2029)
2.4.4 Global Alprostadil Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Alprostadil Injection Sales by Manufacturers
3.1.1 Global Alprostadil Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Alprostadil Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Alprostadil Injection in 2022
3.2 Global Alprostadil Injection Revenue by Manufacturers
3.2.1 Global Alprostadil Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Alprostadil Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Alprostadil Injection Revenue in 2022
3.3 Global Key Players of Alprostadil Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Alprostadil Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Alprostadil Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Alprostadil Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Alprostadil Injection, Product Offered and Application
3.8 Global Key Manufacturers of Alprostadil Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Alprostadil Injection Sales by Type
4.1.1 Global Alprostadil Injection Historical Sales by Type (2018-2024)
4.1.2 Global Alprostadil Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Alprostadil Injection Sales Market Share by Type (2018-2029)
4.2 Global Alprostadil Injection Revenue by Type
4.2.1 Global Alprostadil Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Alprostadil Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Alprostadil Injection Revenue Market Share by Type (2018-2029)
4.3 Global Alprostadil Injection Price by Type
4.3.1 Global Alprostadil Injection Price by Type (2018-2024)
4.3.2 Global Alprostadil Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Alprostadil Injection Sales by Application
5.1.1 Global Alprostadil Injection Historical Sales by Application (2018-2024)
5.1.2 Global Alprostadil Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Alprostadil Injection Sales Market Share by Application (2018-2029)
5.2 Global Alprostadil Injection Revenue by Application
5.2.1 Global Alprostadil Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Alprostadil Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Alprostadil Injection Revenue Market Share by Application (2018-2029)
5.3 Global Alprostadil Injection Price by Application
5.3.1 Global Alprostadil Injection Price by Application (2018-2024)
5.3.2 Global Alprostadil Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Alprostadil Injection Market Size by Type
6.1.1 US & Canada Alprostadil Injection Sales by Type (2018-2029)
6.1.2 US & Canada Alprostadil Injection Revenue by Type (2018-2029)
6.2 US & Canada Alprostadil Injection Market Size by Application
6.2.1 US & Canada Alprostadil Injection Sales by Application (2018-2029)
6.2.2 US & Canada Alprostadil Injection Revenue by Application (2018-2029)
6.3 US & Canada Alprostadil Injection Market Size by Country
6.3.1 US & Canada Alprostadil Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Alprostadil Injection Sales by Country (2018-2029)
6.3.3 US & Canada Alprostadil Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Alprostadil Injection Market Size by Type
7.1.1 Europe Alprostadil Injection Sales by Type (2018-2029)
7.1.2 Europe Alprostadil Injection Revenue by Type (2018-2029)
7.2 Europe Alprostadil Injection Market Size by Application
7.2.1 Europe Alprostadil Injection Sales by Application (2018-2029)
7.2.2 Europe Alprostadil Injection Revenue by Application (2018-2029)
7.3 Europe Alprostadil Injection Market Size by Country
7.3.1 Europe Alprostadil Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Alprostadil Injection Sales by Country (2018-2029)
7.3.3 Europe Alprostadil Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Alprostadil Injection Market Size
8.1.1 China Alprostadil Injection Sales (2018-2029)
8.1.2 China Alprostadil Injection Revenue (2018-2029)
8.2 China Alprostadil Injection Market Size by Application
8.2.1 China Alprostadil Injection Sales by Application (2018-2029)
8.2.2 China Alprostadil Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Alprostadil Injection Market Size by Type
9.1.1 Asia Alprostadil Injection Sales by Type (2018-2029)
9.1.2 Asia Alprostadil Injection Revenue by Type (2018-2029)
9.2 Asia Alprostadil Injection Market Size by Application
9.2.1 Asia Alprostadil Injection Sales by Application (2018-2029)
9.2.2 Asia Alprostadil Injection Revenue by Application (2018-2029)
9.3 Asia Alprostadil Injection Sales by Region
9.3.1 Asia Alprostadil Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Alprostadil Injection Revenue by Region (2018-2029)
9.3.3 Asia Alprostadil Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Alprostadil Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Alprostadil Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Alprostadil Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Alprostadil Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Alprostadil Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Alprostadil Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Alprostadil Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Alprostadil Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Alprostadil Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Alprostadil Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Louston
11.1.1 Louston Company Information
11.1.2 Louston Overview
11.1.3 Louston Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Louston Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Louston Recent Developments
11.2 CP Group
11.2.1 CP Group Company Information
11.2.2 CP Group Overview
11.2.3 CP Group Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CP Group Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CP Group Recent Developments
11.3 Yinglian Biopharmaceutical
11.3.1 Yinglian Biopharmaceutical Company Information
11.3.2 Yinglian Biopharmaceutical Overview
11.3.3 Yinglian Biopharmaceutical Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Yinglian Biopharmaceutical Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Yinglian Biopharmaceutical Recent Developments
11.4 Green Biology
11.4.1 Green Biology Company Information
11.4.2 Green Biology Overview
11.4.3 Green Biology Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Green Biology Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Green Biology Recent Developments
11.5 HPGC
11.5.1 HPGC Company Information
11.5.2 HPGC Overview
11.5.3 HPGC Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 HPGC Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 HPGC Recent Developments
11.6 Swiss Parenterals
11.6.1 Swiss Parenterals Company Information
11.6.2 Swiss Parenterals Overview
11.6.3 Swiss Parenterals Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Swiss Parenterals Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Swiss Parenterals Recent Developments
11.7 Endo Pharm
11.7.1 Endo Pharm Company Information
11.7.2 Endo Pharm Overview
11.7.3 Endo Pharm Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Endo Pharm Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo Pharm Recent Developments
11.8 Ferring Pharmaceuticals
11.8.1 Ferring Pharmaceuticals Company Information
11.8.2 Ferring Pharmaceuticals Overview
11.8.3 Ferring Pharmaceuticals Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Ferring Pharmaceuticals Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ferring Pharmaceuticals Recent Developments
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Company Information
11.9.2 Hikma Pharmaceuticals Overview
11.9.3 Hikma Pharmaceuticals Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Hikma Pharmaceuticals Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hikma Pharmaceuticals Recent Developments
11.10 Lifespan Biotech
11.10.1 Lifespan Biotech Company Information
11.10.2 Lifespan Biotech Overview
11.10.3 Lifespan Biotech Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Lifespan Biotech Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Lifespan Biotech Recent Developments
11.11 Viatris
11.11.1 Viatris Company Information
11.11.2 Viatris Overview
11.11.3 Viatris Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Viatris Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Viatris Recent Developments
11.12 Orifarm Group
11.12.1 Orifarm Group Company Information
11.12.2 Orifarm Group Overview
11.12.3 Orifarm Group Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Orifarm Group Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Orifarm Group Recent Developments
11.13 Pfizer
11.13.1 Pfizer Company Information
11.13.2 Pfizer Overview
11.13.3 Pfizer Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Pfizer Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Recent Developments
11.14 Sandoz
11.14.1 Sandoz Company Information
11.14.2 Sandoz Overview
11.14.3 Sandoz Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Sandoz Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Sandoz Recent Developments
11.15 Teva Pharmaceutical
11.15.1 Teva Pharmaceutical Company Information
11.15.2 Teva Pharmaceutical Overview
11.15.3 Teva Pharmaceutical Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Teva Pharmaceutical Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Teva Pharmaceutical Recent Developments
11.16 Beijing Tide Pharmaceutical
11.16.1 Beijing Tide Pharmaceutical Company Information
11.16.2 Beijing Tide Pharmaceutical Overview
11.16.3 Beijing Tide Pharmaceutical Alprostadil Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Beijing Tide Pharmaceutical Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Beijing Tide Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Alprostadil Injection Industry Chain Analysis
12.2 Alprostadil Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Alprostadil Injection Production Mode & Process
12.4 Alprostadil Injection Sales and Marketing
12.4.1 Alprostadil Injection Sales Channels
12.4.2 Alprostadil Injection Distributors
12.5 Alprostadil Injection Customers
13 Market Dynamics
13.1 Alprostadil Injection Industry Trends
13.2 Alprostadil Injection Market Drivers
13.3 Alprostadil Injection Market Challenges
13.4 Alprostadil Injection Market Restraints
14 Key Findings in The Global Alprostadil Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Alprostadil Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 0.5Mg/Ml
Table 3. Major Manufacturers of 1Mg/Ml
Table 4. Major Manufacturers of 2Mg/Ml
Table 5. Major Manufacturers of Other
Table 6. Global Alprostadil Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Alprostadil Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Alprostadil Injection Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Alprostadil Injection Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Alprostadil Injection Revenue Market Share by Region (2018-2024)
Table 11. Global Alprostadil Injection Revenue Market Share by Region (2024-2029)
Table 12. Global Alprostadil Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Alprostadil Injection Sales by Region (2018-2024) & (Vial)
Table 14. Global Alprostadil Injection Sales by Region (2024-2029) & (Vial)
Table 15. Global Alprostadil Injection Sales Market Share by Region (2018-2024)
Table 16. Global Alprostadil Injection Sales Market Share by Region (2024-2029)
Table 17. Global Alprostadil Injection Sales by Manufacturers (2018-2024) & (Vial)
Table 18. Global Alprostadil Injection Sales Share by Manufacturers (2018-2024)
Table 19. Global Alprostadil Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Alprostadil Injection Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Alprostadil Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Alprostadil Injection Price by Manufacturers 2018-2024 (US$/Vial)
Table 23. Global Alprostadil Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Alprostadil Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alprostadil Injection as of 2022)
Table 25. Global Key Manufacturers of Alprostadil Injection, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Alprostadil Injection, Product Offered and Application
Table 27. Global Key Manufacturers of Alprostadil Injection, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Alprostadil Injection Sales by Type (2018-2024) & (Vial)
Table 30. Global Alprostadil Injection Sales by Type (2024-2029) & (Vial)
Table 31. Global Alprostadil Injection Sales Share by Type (2018-2024)
Table 32. Global Alprostadil Injection Sales Share by Type (2024-2029)
Table 33. Global Alprostadil Injection Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Alprostadil Injection Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Alprostadil Injection Revenue Share by Type (2018-2024)
Table 36. Global Alprostadil Injection Revenue Share by Type (2024-2029)
Table 37. Alprostadil Injection Price by Type (2018-2024) & (US$/Vial)
Table 38. Global Alprostadil Injection Price Forecast by Type (2024-2029) & (US$/Vial)
Table 39. Global Alprostadil Injection Sales by Application (2018-2024) & (Vial)
Table 40. Global Alprostadil Injection Sales by Application (2024-2029) & (Vial)
Table 41. Global Alprostadil Injection Sales Share by Application (2018-2024)
Table 42. Global Alprostadil Injection Sales Share by Application (2024-2029)
Table 43. Global Alprostadil Injection Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Alprostadil Injection Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Alprostadil Injection Revenue Share by Application (2018-2024)
Table 46. Global Alprostadil Injection Revenue Share by Application (2024-2029)
Table 47. Alprostadil Injection Price by Application (2018-2024) & (US$/Vial)
Table 48. Global Alprostadil Injection Price Forecast by Application (2024-2029) & (US$/Vial)
Table 49. US & Canada Alprostadil Injection Sales by Type (2018-2024) & (Vial)
Table 50. US & Canada Alprostadil Injection Sales by Type (2024-2029) & (Vial)
Table 51. US & Canada Alprostadil Injection Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Alprostadil Injection Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Alprostadil Injection Sales by Application (2018-2024) & (Vial)
Table 54. US & Canada Alprostadil Injection Sales by Application (2024-2029) & (Vial)
Table 55. US & Canada Alprostadil Injection Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Alprostadil Injection Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Alprostadil Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Alprostadil Injection Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Alprostadil Injection Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Alprostadil Injection Sales by Country (2018-2024) & (Vial)
Table 61. US & Canada Alprostadil Injection Sales by Country (2024-2029) & (Vial)
Table 62. Europe Alprostadil Injection Sales by Type (2018-2024) & (Vial)
Table 63. Europe Alprostadil Injection Sales by Type (2024-2029) & (Vial)
Table 64. Europe Alprostadil Injection Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Alprostadil Injection Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Alprostadil Injection Sales by Application (2018-2024) & (Vial)
Table 67. Europe Alprostadil Injection Sales by Application (2024-2029) & (Vial)
Table 68. Europe Alprostadil Injection Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Alprostadil Injection Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Alprostadil Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Alprostadil Injection Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Alprostadil Injection Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Alprostadil Injection Sales by Country (2018-2024) & (Vial)
Table 74. Europe Alprostadil Injection Sales by Country (2024-2029) & (Vial)
Table 75. China Alprostadil Injection Sales by Type (2018-2024) & (Vial)
Table 76. China Alprostadil Injection Sales by Type (2024-2029) & (Vial)
Table 77. China Alprostadil Injection Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Alprostadil Injection Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Alprostadil Injection Sales by Application (2018-2024) & (Vial)
Table 80. China Alprostadil Injection Sales by Application (2024-2029) & (Vial)
Table 81. China Alprostadil Injection Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Alprostadil Injection Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Alprostadil Injection Sales by Type (2018-2024) & (Vial)
Table 84. Asia Alprostadil Injection Sales by Type (2024-2029) & (Vial)
Table 85. Asia Alprostadil Injection Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Alprostadil Injection Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Alprostadil Injection Sales by Application (2018-2024) & (Vial)
Table 88. Asia Alprostadil Injection Sales by Application (2024-2029) & (Vial)
Table 89. Asia Alprostadil Injection Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Alprostadil Injection Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Alprostadil Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Alprostadil Injection Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Alprostadil Injection Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Alprostadil Injection Sales by Region (2018-2024) & (Vial)
Table 95. Asia Alprostadil Injection Sales by Region (2024-2029) & (Vial)
Table 96. Middle East, Africa and Latin America Alprostadil Injection Sales by Type (2018-2024) & (Vial)
Table 97. Middle East, Africa and Latin America Alprostadil Injection Sales by Type (2024-2029) & (Vial)
Table 98. Middle East, Africa and Latin America Alprostadil Injection Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Alprostadil Injection Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Alprostadil Injection Sales by Application (2018-2024) & (Vial)
Table 101. Middle East, Africa and Latin America Alprostadil Injection Sales by Application (2024-2029) & (Vial)
Table 102. Middle East, Africa and Latin America Alprostadil Injection Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Alprostadil Injection Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Alprostadil Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Alprostadil Injection Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Alprostadil Injection Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Alprostadil Injection Sales by Country (2018-2024) & (Vial)
Table 108. Middle East, Africa and Latin America Alprostadil Injection Sales by Country (2024-2029) & (Vial)
Table 109. Louston Company Information
Table 110. Louston Description and Major Businesses
Table 111. Louston Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 112. Louston Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Louston Recent Developments
Table 114. CP Group Company Information
Table 115. CP Group Description and Major Businesses
Table 116. CP Group Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 117. CP Group Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. CP Group Recent Developments
Table 119. Yinglian Biopharmaceutical Company Information
Table 120. Yinglian Biopharmaceutical Description and Major Businesses
Table 121. Yinglian Biopharmaceutical Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 122. Yinglian Biopharmaceutical Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Yinglian Biopharmaceutical Recent Developments
Table 124. Green Biology Company Information
Table 125. Green Biology Description and Major Businesses
Table 126. Green Biology Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 127. Green Biology Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Green Biology Recent Developments
Table 129. HPGC Company Information
Table 130. HPGC Description and Major Businesses
Table 131. HPGC Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 132. HPGC Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. HPGC Recent Developments
Table 134. Swiss Parenterals Company Information
Table 135. Swiss Parenterals Description and Major Businesses
Table 136. Swiss Parenterals Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 137. Swiss Parenterals Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Swiss Parenterals Recent Developments
Table 139. Endo Pharm Company Information
Table 140. Endo Pharm Description and Major Businesses
Table 141. Endo Pharm Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 142. Endo Pharm Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Endo Pharm Recent Developments
Table 144. Ferring Pharmaceuticals Company Information
Table 145. Ferring Pharmaceuticals Description and Major Businesses
Table 146. Ferring Pharmaceuticals Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 147. Ferring Pharmaceuticals Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Ferring Pharmaceuticals Recent Developments
Table 149. Hikma Pharmaceuticals Company Information
Table 150. Hikma Pharmaceuticals Description and Major Businesses
Table 151. Hikma Pharmaceuticals Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 152. Hikma Pharmaceuticals Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Hikma Pharmaceuticals Recent Developments
Table 154. Lifespan Biotech Company Information
Table 155. Lifespan Biotech Description and Major Businesses
Table 156. Lifespan Biotech Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 157. Lifespan Biotech Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Lifespan Biotech Recent Developments
Table 159. Viatris Company Information
Table 160. Viatris Description and Major Businesses
Table 161. Viatris Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 162. Viatris Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Viatris Recent Developments
Table 164. Orifarm Group Company Information
Table 165. Orifarm Group Description and Major Businesses
Table 166. Orifarm Group Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 167. Orifarm Group Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Orifarm Group Recent Developments
Table 169. Pfizer Company Information
Table 170. Pfizer Description and Major Businesses
Table 171. Pfizer Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 172. Pfizer Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Pfizer Recent Developments
Table 174. Sandoz Company Information
Table 175. Sandoz Description and Major Businesses
Table 176. Sandoz Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 177. Sandoz Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Sandoz Recent Developments
Table 179. Teva Pharmaceutical Company Information
Table 180. Teva Pharmaceutical Description and Major Businesses
Table 181. Teva Pharmaceutical Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 182. Teva Pharmaceutical Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Teva Pharmaceutical Recent Developments
Table 184. Beijing Tide Pharmaceutical Company Information
Table 185. Beijing Tide Pharmaceutical Description and Major Businesses
Table 186. Beijing Tide Pharmaceutical Alprostadil Injection Sales (Vial), Revenue (US$ Million), Price (US$/Vial) and Gross Margin (2018-2024)
Table 187. Beijing Tide Pharmaceutical Alprostadil Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Beijing Tide Pharmaceutical Recent Developments
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Alprostadil Injection Distributors List
Table 192. Alprostadil Injection Customers List
Table 193. Alprostadil Injection Market Trends
Table 194. Alprostadil Injection Market Drivers
Table 195. Alprostadil Injection Market Challenges
Table 196. Alprostadil Injection Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Alprostadil Injection Product Picture
Figure 2. Global Alprostadil Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Alprostadil Injection Market Share by Type in 2022 & 2029
Figure 4. 0.5Mg/Ml Product Picture
Figure 5. 1Mg/Ml Product Picture
Figure 6. 2Mg/Ml Product Picture
Figure 7. Other Product Picture
Figure 8. Global Alprostadil Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Alprostadil Injection Market Share by Application in 2022 & 2029
Figure 10. Myocardial Infarction
Figure 11. Thrombotic Vasculitis
Figure 12. Occlusive Arteriosclerosis
Figure 13. Other
Figure 14. Alprostadil Injection Report Years Considered
Figure 15. Global Alprostadil Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Alprostadil Injection Revenue 2018-2029 (US$ Million)
Figure 17. Global Alprostadil Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Alprostadil Injection Revenue Market Share by Region (2018-2029)
Figure 19. Global Alprostadil Injection Sales 2018-2029 ((Vial)
Figure 20. Global Alprostadil Injection Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Alprostadil Injection Sales YoY (2018-2029) & (Vial)
Figure 22. US & Canada Alprostadil Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Alprostadil Injection Sales YoY (2018-2029) & (Vial)
Figure 24. Europe Alprostadil Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Alprostadil Injection Sales YoY (2018-2029) & (Vial)
Figure 26. China Alprostadil Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Alprostadil Injection Sales YoY (2018-2029) & (Vial)
Figure 28. Asia (excluding China) Alprostadil Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Alprostadil Injection Sales YoY (2018-2029) & (Vial)
Figure 30. Middle East, Africa and Latin America Alprostadil Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Alprostadil Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Alprostadil Injection in the World: Market Share by Alprostadil Injection Revenue in 2022
Figure 33. Global Alprostadil Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Alprostadil Injection Sales Market Share by Type (2018-2029)
Figure 35. Global Alprostadil Injection Revenue Market Share by Type (2018-2029)
Figure 36. Global Alprostadil Injection Sales Market Share by Application (2018-2029)
Figure 37. Global Alprostadil Injection Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Alprostadil Injection Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Alprostadil Injection Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Alprostadil Injection Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Alprostadil Injection Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Alprostadil Injection Revenue Share by Country (2018-2029)
Figure 43. US & Canada Alprostadil Injection Sales Share by Country (2018-2029)
Figure 44. U.S. Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Alprostadil Injection Sales Market Share by Type (2018-2029)
Figure 47. Europe Alprostadil Injection Revenue Market Share by Type (2018-2029)
Figure 48. Europe Alprostadil Injection Sales Market Share by Application (2018-2029)
Figure 49. Europe Alprostadil Injection Revenue Market Share by Application (2018-2029)
Figure 50. Europe Alprostadil Injection Revenue Share by Country (2018-2029)
Figure 51. Europe Alprostadil Injection Sales Share by Country (2018-2029)
Figure 52. Germany Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 53. France Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 57. China Alprostadil Injection Sales Market Share by Type (2018-2029)
Figure 58. China Alprostadil Injection Revenue Market Share by Type (2018-2029)
Figure 59. China Alprostadil Injection Sales Market Share by Application (2018-2029)
Figure 60. China Alprostadil Injection Revenue Market Share by Application (2018-2029)
Figure 61. Asia Alprostadil Injection Sales Market Share by Type (2018-2029)
Figure 62. Asia Alprostadil Injection Revenue Market Share by Type (2018-2029)
Figure 63. Asia Alprostadil Injection Sales Market Share by Application (2018-2029)
Figure 64. Asia Alprostadil Injection Revenue Market Share by Application (2018-2029)
Figure 65. Asia Alprostadil Injection Revenue Share by Region (2018-2029)
Figure 66. Asia Alprostadil Injection Sales Share by Region (2018-2029)
Figure 67. Japan Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 71. India Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Alprostadil Injection Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Alprostadil Injection Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Alprostadil Injection Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Alprostadil Injection Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Alprostadil Injection Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Alprostadil Injection Sales Share by Country (2018-2029)
Figure 78. Brazil Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Alprostadil Injection Revenue (2018-2029) & (US$ Million)
Figure 83. Alprostadil Injection Value Chain
Figure 84. Alprostadil Injection Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices